The final day of the Third Annual World Cutaneous Malignancies Congress (WCMC) opened with a Breakfast Product Theater titled “Management of Early-Stage (IA and IB) Mycosis Fungoides–Type Cutaneous T-Cell Lymphoma (MF-CTCL) and VALCHLOR Clinical Overview,” presented by Dr. Larisa Geskin and sponsored by Actelion.

View Digital Edition